Oğuzhan Ayrancıoğlu
Oğuzhan Ayrancıoğlu has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Ceren Akagündüz Ayrancıoğlu
Dokuz Eylül University, Institute of Health Sciences, Department of Medical Physics, Izmir, 35340, Turkey; Izmir Tinaztepe University, Vocational School of Health Services, Autopsy Assistance Program, Izmir, 35400, Turkey
2 shared publications - Zumre Arican Alicikus
Department of Radiation Oncology, School of Medicine, Dokuz Eylul University, Izmir, Turkey
2 shared publications Ceren Ayrancioğlu
1 shared publication- Duygu Akbaş Uysal
Izmir Kavram Vocational School, İzmir, Turkey
1 shared publication Fısun Senuzun Aykar
Izmir Tınaztepe Unıversty, Türkiye
1 shared publicationGizem Şişman
1 shared publication
Latest Publications
- 23 March 2026
- Published by SAGE Publications in Clinical Nursing Research
- Vol. 35 (4) , 171-181
Effect of Music Intervention on Pain, Anxiety, and Vital Signs in Radiotherapy Patients: A Randomized Controlled Trial Based on the Roy Adaptation Model
Cancer is the second leading cause of death globally, following cardiovascular diseases. Radiotherapy (RT), a common cancer treatment modality, often induces both physical discomfort and psychological distress, including pain and anxiety. Although music interventions have shown promise in reducing such symptoms, most studies lack a theoretical foundation, limiting their generalizability and application in nursing practice. This study aimed to evaluate the effects of a music intervention on pain, anxiety, and vital signs in patients undergoing RT, using the Roy Adaptation Model (RAM) as the theoretical framework. A randomized controlled trial was conducted between May 2024 and April 2025 in the Radiation Oncology Department. A total of 120 patients were randomly assigned to either the intervention group ( n = 60) or control group ( n = 60). The intervention group listened to specially composed therapeutic music via speakers for 20 to 40 min during weekly RT sessions. Pain (Visual Analog Scale), anxiety (Facial Anxiety Scale), and vital signs (blood pressure, heart rate, and respiratory rate) were measured before and after RT sessions. Data were analyzed using paired-sample t-tests and Cohen’s d for effect sizes. The music intervention significantly reduced pain and anxiety scores in the intervention group compared to the control group ( p < .001). Additionally, positive changes in vital signs were observed, including decreased systolic blood pressure and heart rate. The findings support the regulatory and cognator adaptive responses described in RAM, indicating that music functions as an effective coping mechanism for physiological and psychological stressors during RT. Music intervention is a safe, non-pharmacological, and cost-effective strategy for enhancing patient adaptation during RT. This study contributes to the evidence base by integrating a theoretical model into clinical nursing practice and underscores the importance of model-based interventions in improving holistic patient care.
- 23 March 2026
- Published by SAGE Publications in Clinical Nursing Research
- Vol. 35 (4) , 171-181
Effect of Music Intervention on Pain, Anxiety, and Vital Signs in Radiotherapy Patients: A Randomized Controlled Trial Based on the Roy Adaptation Model
Cancer is the second leading cause of death globally, following cardiovascular diseases. Radiotherapy (RT), a common cancer treatment modality, often induces both physical discomfort and psychological distress, including pain and anxiety. Although music interventions have shown promise in reducing such symptoms, most studies lack a theoretical foundation, limiting their generalizability and application in nursing practice. This study aimed to evaluate the effects of a music intervention on pain, anxiety, and vital signs in patients undergoing RT, using the Roy Adaptation Model (RAM) as the theoretical framework. A randomized controlled trial was conducted between May 2024 and April 2025 in the Radiation Oncology Department. A total of 120 patients were randomly assigned to either the intervention group ( n = 60) or control group ( n = 60). The intervention group listened to specially composed therapeutic music via speakers for 20 to 40 min during weekly RT sessions. Pain (Visual Analog Scale), anxiety (Facial Anxiety Scale), and vital signs (blood pressure, heart rate, and respiratory rate) were measured before and after RT sessions. Data were analyzed using paired-sample t-tests and Cohen’s d for effect sizes. The music intervention significantly reduced pain and anxiety scores in the intervention group compared to the control group ( p < .001). Additionally, positive changes in vital signs were observed, including decreased systolic blood pressure and heart rate. The findings support the regulatory and cognator adaptive responses described in RAM, indicating that music functions as an effective coping mechanism for physiological and psychological stressors during RT. Music intervention is a safe, non-pharmacological, and cost-effective strategy for enhancing patient adaptation during RT. This study contributes to the evidence base by integrating a theoretical model into clinical nursing practice and underscores the importance of model-based interventions in improving holistic patient care.
- 29 October 2025
- Published by Elsevier in Medical Dosimetry
- Vol. 51 (1) , 91-102
Treatment plan selection in whole left breast radiotherapy using multi-criteria decision-making methods: A phantom study
- 29 October 2025
- Published by Elsevier in Medical Dosimetry
- Vol. 51 (1) , 91-102
Treatment plan selection in whole left breast radiotherapy using multi-criteria decision-making methods: A phantom study
- 15 March 2024
- Published by Springer Nature in Journal of the Korean Physical Society
- Vol. 84 (10) , 799-811
A novel approach to quality assurance of radiation treatments with a visual interface of GEANT4 for Varian TrueBeam STx
- 15 March 2024
- Published by Springer Nature in Journal of the Korean Physical Society
- Vol. 84 (10) , 799-811
A novel approach to quality assurance of radiation treatments with a visual interface of GEANT4 for Varian TrueBeam STx
- 5 February 2024
- Published by Elsevier in Medical Dosimetry
- Vol. 49 (3) , 222-228
Performance assessment of the surface-guided radiation therapy system: Varian Identify
- 5 February 2024
- Published by Elsevier in Medical Dosimetry
- Vol. 49 (3) , 222-228
Performance assessment of the surface-guided radiation therapy system: Varian Identify
- 1 January 2024
- Published by LookUs Bilisim A.S. in Turkish Journal of Oncology
- Vol. 39 (1) , 27-38
Comparison of the Sensitive Volume Response of the Three Different Cylindrical Ionization Chambers with GEANT4 Simulations Using the Concept of Output Factor
- 1 January 2024
- Published by LookUs Bilisim A.S. in Turkish Journal of Oncology
- Vol. 39 (1) , 27-38
Comparison of the Sensitive Volume Response of the Three Different Cylindrical Ionization Chambers with GEANT4 Simulations Using the Concept of Output Factor
- Open Access
- 26 September 2023
- Published by MDPI AG in Current Oncology
- Vol. 30 (10) , 8763-8773
Dose Volume and Liver Function Test Relationship following Radiotheraphy for Right Breast Cancer: A Multicenter Study
Objective: The liver is a critical organ at risk during right breast radiotherapy (RT). Liver function tests (LFTs) such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma-glutamyl transferase (GGT) serve as biochemical markers for hepatobiliary damage. In this multicenter cross-sectional study, the effects of liver dose–volume on changes in LFTs pre- and post-RT in patients treated for right breast cancer were evaluated. Materials and Methods: Between January 2019 and November 2022, data from 100 patients who underwent adjuvant right breast RT across three centers were retrospectively assessed. Target volumes and normal structures were contoured per the RTOG atlas. Patients were treated with a total dose of 50 Gy in 25 fractions to the CTV, followed by a boost to the tumor bed where indicated. The percentage change in LFT values in the first two weeks post-RT was calculated. Statistics were analyzed with SPSS version 22 software, with significance set at p < 0.05. Statistical correlation between liver doses (in cGy) and the volume receiving specific doses (Vx in cc) on the change in LFTs were analyzed using Kolmogorov–Smirnov, Mann–Whitney U test. Results: The median age among the 100 patients was 56 (range: 29–79). Breast-conserving surgery was performed on 75% of the patients. The most common T and N stages were T1 (53%) and N0 (53%), respectively. None of the patients had distant metastasis or simultaneous systemic treatment with RT. A total of 67% of the treatments utilized the IMRT technique and 33% VMAT. The median CTV volume was 802 cc (range: 214–2724 cc). A median boost dose of 10 Gy (range: 10–16 Gy) was applied to 28% of the patients with electrons and 51% with IMRT/VMAT. The median liver volume was 1423 cc (range: 825–2312 cc). Statistical analyses were conducted on a subset of 57 patients for whom all three LFT values were available both pre- and post-RT. In this group, the median values for AST, ALT, and GGT increased up to 15% post-RT compared to pre-RT, and a median liver Dmean below 208 cGy was found significant. While many factors can influence LFT values, during RT planning, attention to liver doses and subsequent regular LFT checks are crucial. Conclusion: Due to factors such as anatomical positioning, planning technique, and breast posture, the liver can receive varying doses during right breast irradiation. Protecting patients from liver toxicity secondary to RT is valuable, especially in breast cancer patients with a long-life expectancy. Our study found that, even in the absence of any systemic treatment or risk factors, there was an average increase of nearly 15% in enzymes, indicating acute liver damage post-RT compared with pre-RT. Attention to liver doses during RT planning and regular follow-up with LFTs is essential.
- 26 September 2023
- Published by MDPI AG in Current Oncology
- Vol. 30 (10) , 8763-8773
Open AccessDose Volume and Liver Function Test Relationship following Radiotheraphy for Right Breast Cancer: A Multicenter Study
Objective: The liver is a critical organ at risk during right breast radiotherapy (RT). Liver function tests (LFTs) such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma-glutamyl transferase (GGT) serve as biochemical markers for hepatobiliary damage. In this multicenter cross-sectional study, the effects of liver dose–volume on changes in LFTs pre- and post-RT in patients treated for right breast cancer were evaluated. Materials and Methods: Between January 2019 and November 2022, data from 100 patients who underwent adjuvant right breast RT across three centers were retrospectively assessed. Target volumes and normal structures were contoured per the RTOG atlas. Patients were treated with a total dose of 50 Gy in 25 fractions to the CTV, followed by a boost to the tumor bed where indicated. The percentage change in LFT values in the first two weeks post-RT was calculated. Statistics were analyzed with SPSS version 22 software, with significance set at p < 0.05. Statistical correlation between liver doses (in cGy) and the volume receiving specific doses (Vx in cc) on the change in LFTs were analyzed using Kolmogorov–Smirnov, Mann–Whitney U test. Results: The median age among the 100 patients was 56 (range: 29–79). Breast-conserving surgery was performed on 75% of the patients. The most common T and N stages were T1 (53%) and N0 (53%), respectively. None of the patients had distant metastasis or simultaneous systemic treatment with RT. A total of 67% of the treatments utilized the IMRT technique and 33% VMAT. The median CTV volume was 802 cc (range: 214–2724 cc). A median boost dose of 10 Gy (range: 10–16 Gy) was applied to 28% of the patients with electrons and 51% with IMRT/VMAT. The median liver volume was 1423 cc (range: 825–2312 cc). Statistical analyses were conducted on a subset of 57 patients for whom all three LFT values were available both pre- and post-RT. In this group, the median values for AST, ALT, and GGT increased up to 15% post-RT compared to pre-RT, and a median liver Dmean below 208 cGy was found significant. While many factors can influence LFT values, during RT planning, attention to liver doses and subsequent regular LFT checks are crucial. Conclusion: Due to factors such as anatomical positioning, planning technique, and breast posture, the liver can receive varying doses during right breast irradiation. Protecting patients from liver toxicity secondary to RT is valuable, especially in breast cancer patients with a long-life expectancy. Our study found that, even in the absence of any systemic treatment or risk factors, there was an average increase of nearly 15% in enzymes, indicating acute liver damage post-RT compared with pre-RT. Attention to liver doses during RT planning and regular follow-up with LFTs is essential.